Autor: |
Taillandier A; Department of Pathology, University Hospital of Tours, Tours, France., Legrand M; Department of Pathology, University Hospital of Tours, Tours, France., Petereau A; Department of Pathology, University Hospital of Tours, Tours, France., Tallet A; Platform of Solid Tumor Molecular Genetics, University Hospital Center of Tours, Tours, France., Collin C; Platform of Solid Tumor Molecular Genetics, University Hospital Center of Tours, Tours, France., Frouin E; CARADERM, French Network of Rare Cutaneous Cancer, France.; Department of Pathology, University Hospital of Nimes, University of Nimes, Nimes, France., Jullie ML; CARADERM, French Network of Rare Cutaneous Cancer, France.; Department of Pathology, University Hospital of Bordeaux, Bordeaux, France., Macagno N; CARADERM, French Network of Rare Cutaneous Cancer, France.; Department of Pathology, APHM, Timone University Hospital, Marseille, France.; Aix-Marseille University, INSERM U1251, MMG, Marseille, France., Battistella M; CARADERM, French Network of Rare Cutaneous Cancer, France.; Department of Pathology, Hospital Saint-Louis, AP-HP, Université Paris Cité, INSERM U976, Paris, France., Kervarrec T; Department of Pathology, University Hospital of Tours, Tours, France.; CARADERM, French Network of Rare Cutaneous Cancer, France.; Biologie des Infections à Polyomavirus Team, UMR1282 INRAE, University of Tours, Tours, France. |